WHC is still in active development. Read this to understand our approach.
depiction of RTHCYVBBDHJXIQ-UHFFFAOYSA-N.svg
tripsit

fluoxetine

Check on tripsit

isomerdesign

Fluoxetine

Check on isomerdesign

pubchem

Fluoxetine

Check on pubchem

drugmap

Fluoxetine

Check on drugmap

wiki

Fluoxetine

Check on wiki

Data

InChI: InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3

Synonyms: (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine, Pulvules, (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,N-methyl-3-[4-(trifluoromethyl)phenoxy]-3-(3-tritiophenyl)propan-1-amine,BBL012251,BPBio1_000354, Fluoxetina,Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine,BPBio1_000509,AB9783, Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine,Fluval,Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, (.+/-.)-,Tox21_110144_1,AB00053774-14,Benzenepropanamine, N-methyl-gamma-[4-(trifluoromethyl)phenoxy]-, (+/-)-,Fluoxetinum,AB00053774,NSC 283480, Fluoxetine [USAN:INN:BAN],Fluoxetin,MFCD00072041,Benzenepropamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-,(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine,HY-B0102,Epitope ID:224550,N-Methyl-3-phenyl-3-(p-trifluoromethylphenoxy)propylamine,Eufor,N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine,(.+/-.)-N-Methyl-3-phenyl-3-[(.alpha.,la,.alpha.-trifluoro-p-tolyl)oxy]propylamine,FLUOXETINE [EMA EPAR VETERINARY], (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine,N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine,L000931, Floxetine,SDCCGSBI-0050541.P004, Fluval,Fluoxetin ratiopharm,GTPL203,DivK1c_006819,(.+/-.)-N-Methyl-3-phenyl-3-[(.alpha.,.alpha.,.alpha.-trifluoro-p-tolyl)oxy]propylamine,Spectrum4_000613,Fluoxetina,Benzenepropanamine, N-methyl-?-[4-(trifluoromethyl)phenoxy]-,Fluoxetine (USAN/INN),methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amine hydrochloride, Dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine, Fluoxetinum [INN-Latin],DTXSID7023067,AB00053774-13,KBio2_007295,Fluoxetine [USAN:INN:BAN],LY-110140 free base,STK734483, Fluoxetin,N-methyl 3-(p-trifluoromethylphenoxy)-3-phenylpropylamine,N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine, Fluoxetina [INN-Spanish],DB00472,KBioGR_001166,3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine,BSPBio_000461, Fluoxetine Hcl,DSSTox_GSID_23067,BRD-A31159102-003-05-6, Fluoxetine (Prozac),DSSTox_CID_3067,N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine #, Fluoxetine (USAN/INN), Lilly-110140,UNII-01K63SUP8D,SBI-0050541.P003,NSC283480, (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine,Fluoxetine (TN),Prozac,(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine,DSSTox_RID_76861,Fluoxetina [INN-Spanish],Fluctine,NCGC00015428-07,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,KBio3_002595,AB00053774_16,BDBM30130, Prozac (TN),AKOS003663021, Fluoxetinum, (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine,Prestwick1_000511,Portal,CHEBI:5118, Fluoxetine (TN), Animex-On,NS-140,cid_62857,NCGC00015428-12,DB-015148,N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine,Spectrum5_001518,SPBio_001815,AMY32526,(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine],FT-0626489,N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine, Portal,01K63SUP8D, Reneuron,Spectrum3_001648,FLUOXETINE [VANDF],Prestwick2_000511,SR-01000002988-18,Q422244,dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine,Spectrum2_001658,BRD-A31159102-001-01-9,Animex-On,NSC-758685,CCG-204648,ALBB-025606,Fluoxac,BCP28440,Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine,sarafem, Fontex,N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)BENZENEPROPANAMINE,FLUOXETINE [WHO-DD], N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine,CAS-54910-89-3,AB00053774_15,Spectrum_001679,AC-8478,SCHEMBL8353,Lopac0_000558, (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine,NCGC00015428-06,KBio2_002159, 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine, N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine,D00326,Prestwick0_000511,NCGC00024879-04, N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine,NSC-283480,HMS2090H14,Prestwick3_000511, Fluoxetina [Spanish],(+/-)-N-METHYL-3-PHENYL-3-((.ALPHA.,ALPHA.,.ALPHA.-TRIFLUORO-P-TOLYL)OXY)PROPYLAMINE,Symbyax,benzenepropanamine, N-methyl-gamma-[4-(trifluoromethyl)phenoxy]-,SPBio_002382,FLUOXETINE [INN],Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-,KBio1_001763,NCGC00024879-03,SpecPlus_000723,NSC 758685,DL-N-METHYL-3-(P-TRIFLUOROMETHYLPHENOXY)-3-PHENYLPROPYLAMINE, Prozac Weekly,KBioSS_002159,Selfemra,KBio2_004727,NCGC00015428-15,EN300-199668,Pulvules, Reconcile, Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine,fluoxetine,AS-44989,Lilly-110140,Tox21_110144,BSPBio_003375,(+/-)-Fluoxetine,(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine,(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine, N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,NCGC00015428-27,Fludac,CHEMBL41,Fluoxetina [Spanish],54910-89-3,NCGC00015428-10,FLUOXETINE [MI],(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine,Fluxil,LY-110140;LY 110140;LY110140,prozac,Biomol-NT_000152,HSDB 6633,n-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine,CHEBI:86990, (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine], (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine,BENZENEPROPANAMINE, N-METHYL-G-(4-(TRIFLUOROMETHYL)PHENOXY)-, (+/-)-,57226-07-0,Fluoxetinum [INN-Latin],FLUOXETINE [USAN],NCGC00015428-13,BRD-A31159102-003-16-3,NCGC00015428-08,(+/-) -Fluoxetine,NCGC00015428-11,Fluoxetine


Estimated data

Solubility: -3.82 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 42.9% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.